Navigation Links
UE LifeSciences Launches WeMustTry.com Crowdfunding Campaign for Low-cost, Painless Breast Cancer Screening Services Focused on Developing Countries
Date:10/22/2013

PHILADELPHIA, Oct. 22, 2013 /PRNewswire/ -- UE LifeSciences Inc. (UELS), medical device maker of innovative breast cancer detection tools, has announced a crowd-funding campaign to help fight breast cancer. The 'We Must Try' campaign will offer 25,000 women painless and radiation-free breast examinations at several clinics in India, Mexico, Panama, Brazil and Egypt.

(Photo: http://photos.prnewswire.com/prnh/20131022/PH01810-a )

(Photo: http://photos.prnewswire.com/prnh/20131022/PH01810-b )

"The goal is to identify breast cancers earlier to directly and positively impact treatment outcomes and extend quality life," said Dr. Ari Brooks, Director of the Integrated Breast Center at Pennsylvania Hospital. "We Must Try has this goal at the heart of its campaign."

"7 out of 10 breast cancer deaths are now occurring in low-resource countries where mammography screening, the only known model for early detection, is virtually impossible to implement at a large scale," says Dr. Mahesh Shetty, Clinical Professor of Radiology, Baylor College of Medicine. "We need a paradigm shift, a model that works specifically for low-resource regions," he added.

The 'We Must Try' campaign will bring a set of non-invasive and easy-to-use early detection tools developed by UE LifeSciences to areas where the vast majority of breast cancer cases are reported at late stages, with poor prognosis. A detailed report at the end of the project will be shared with health authorities in several developing countries to help establish a new, sustainable framework for breast cancer detection.

UELS' NoTouch BreastScan (NTBS, www.NoTouchBreastScan.com) device is a contact-free breast-imaging tool cleared by the FDA (Feb. 2012) for the detection of breast cancer. UELS is also developing the Intelligent Breast Exam (iBE, www.iBreastExam.com), a novel hand-held, battery-powered, and wireless breast scanner backed by the CURE grant award (Aug 2012) from the Pennsylvania Department of Health. The campaign will offer both inventions together in a "multi-modality" approach to detect breast cancer early. "It's a brand new toolkit - one that is easy to deploy with health workers and one that helps women to step forward for comfortable, low-cost and pain-free examinations routinely," said Prof. Matthew Campisi, chief technology officer of UELS.

A five-minute online film showcases the campaign at www.WeMustTry.com. It is a not-for-profit project looking for philanthropic contributions and corporate sponsorship to help cover the cost of 25,000 breast exams at $10 per woman examined. UE LifeSciences and several doctors from each region are offering resources as necessary to accomplish the cause.

Nearly 10 million healthy and productive life years are being lost prematurely to breast cancer in low-income parts of the world as per the World Health Organization. "We are absolutely committed to curb this unfortunate, unacceptable and unsustainable loss. Mothers, sisters, wives and friends in the developing world deserve a fighting chance. We Must Try." says Mihir Shah, founder and CEO of UELS.

About UE LifeSciences Inc.
UE LifeSciences Inc. (UELS) is a Philadelphia, PA-based corporation with a mission to design, develop and commercialize globally adoptable and clinically effective non-invasive breast cancer detection solutions for women of all ages and demographics.

Media Contacts
Mihir Shah, +1 (631) 980-8340, Email

Read more news from UE LifeSciences Inc.


'/>"/>
SOURCE UE LifeSciences Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. Atharva Lifesciences Consulting Releases the Biggest Ever Compilation of Science Funding Sources for India
2. ActiGraph Launches New Generation of Bluetooth® Smart Activity Monitors
3. KromaTiD Launches dGH Chromatid-specific Assays
4. MO BIO Laboratories, Inc. launches a new kit for rapid release of microbial DNA from swabs for PCR analysis
5. Portal Solutions Launches AuthentiMate™ a “Bring Your Own SharePoint Identity” Solution
6. Ventana launches first fully automated IHC test to detect BRAF V600E mutation in a variety of cancers
7. Castle Biosciences Launches Tissue Repository for Eye Cancer Patients
8. Convey Computer Launches Hybrid-Core Memcached Appliance – Speeds Performance, Reduces Cost of Ownership
9. Dr. Singh and Apollonia Dental Launches Ground-Breaking Cavity Prevention Program That Can Lower Decay Rates by 74%
10. Tor/Forge Launches THE CURE, a Riveting Thriller in the Tradition of Michael Crichton, by the New York Times Bestselling Author of WIRED.
11. Meso Scale Discovery Launches V-PLEX™ Multiplex Biomarker Immunoassays
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/20/2017)... PA (PRWEB) , ... February ... ... to improve therapeutic success among radiotherapy patients, prevent chest wall collapses in ... femur fracture alignments will receive a total of $600,000 in funding through ...
(Date:2/20/2017)... -- Former NFL players who had repeated head injuries may not ... to a preliminary study released today that will be presented ... Boston , April 22 to 28, 2017. ... muscles and nerves work together, like walking, kicking and writing. ... Repeated ...
(Date:2/20/2017)...  Atrius Health and IBM (NYSE: IBM ... to develop a cloud based service designed to ... view of the multiple influences on an individual,s ... be designed to support shared decision making between ... nonprofit healthcare organization with 875 physicians caring for ...
(Date:2/18/2017)... Kurzlehrgang mit Fokus auf ... Poster legt metaproteomische Analyse des Darm-Mikrobioms bei Säuglingen dar   ... ... Yoav Peretz , Scientific Director bei ImmuneCarta, einen ... zum Nachweis intrazellulärer Zytokine bei adoptiven Zelltherapie-Studien im Rahmen ...
Breaking Biology Technology:
(Date:2/8/2017)... Feb. 7, 2017 Report Highlights ... 2021 from $8.3 billion in 2016 at a compound ... 2021. Report Includes - An overview of the ... trends, with data from 2015 and 2016, and projections ... Segmentation of the market on the basis of product ...
(Date:2/3/2017)... 3, 2017  Texas Biomedical Research Institute announced that its ... Schlesinger as the Institute,s new President and CEO. Dr. ... 31, 2017. He is currently the Chair of the Department ... for Microbial Interface Biology at Ohio State University. ... President and CEO of Texas Biomed," said Dr. James ...
(Date:2/1/2017)... BOSTON, Massachusetts , February 1, 2017 ... and events on emerging technology, announces the availability of a new ... Continue Reading ... ... systems in industrial and collaborative robots. Source: IDTechEx Report "Sensors for ...
Breaking Biology News(10 mins):